International Psoriasis Council

Advancing Knowledge. Improving Care.

Curdin Conrad Headshot

Curdin

Conrad

,

MD

Dermatology of Dermatology Functions, Head of the Policlinics and the Center for Psoriasis
University Hospital of Lausanne
Lausanne
,
Switzerland
Councilor Since: October 1, 2016
IPC Board Member
Dr. Curdin Conrad is a Professor of Dermatology at Lausanne University Hospital in Switzerland. He received his MD training at the University of Zurich and participated in the Postgraduate Course of Experimental Medicine and Biology. After completing dermatology training, he was a research fellow at MD Anderson Cancer Center in Houston, Texas, United States.

Dr. Conrad has a strong interest in inflammatory skin diseases, adaptive and innate immunity, and targeted immunotherapies, spanning basic science, translational research, and the clinic. He has fundamentally contributed to today’s understanding of psoriasis pathogenesis and has received several scientific awards for his basic and translational research. Over the years, Dr. Conrad has been actively involved in the teaching of evidence-based clinical and scientific dermatology and immunology.

He serves as an external scientific expert for several international societies and foundations. Dr. Conrad is a Board Member of the International Psoriasis Council (IPC), a member of the Board of Directors of the International Societies for Investigative Dermatology (ISID), and the current President of the European Society for Dermatological Research (ESDR).
Last Updated:
03/04/2026

Areas of Interest

Basic, Translational, & Clinical Research on Psoriasis, Psoriasis Subtypes, Biologic Treatments, and Side Effects

IPC Committees / Groups

Board Member, Research Committee

Languages Spoken

English, French, German

Involvement with Other Organization(s)

Dr. Conrad is a scientific advisor to the Swiss patient association and an advisor to Swiss national regulatory agencies (the Federal Office of Public Health and Swissmedic).

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026